Cango sets July 20 effective date for 10-for-1 share consolidation amid NYSE price deficiency
Cango (NYSE: CANG) set July 20 as the effective date for a 10-for-1 reverse share consolidation of its Class A and Class B ordinary shares, with post-split trading expected July 21. The NYSE had issued a minimum-price deficiency notice in March after the Class A average closed below $1 for 30 days. Compliance requires $1 closes and a $1 30-day average.
How this was made
The 30-second read
Why it matters
The company selected the maximum allowed 10-for-1 consolidation ratio and set a specific effective date, but it remains subject to NYSE closing-price and 30-trading-day average requirements during the cure period.
Market read
This is a defined corporate action tied to an exchange compliance process, creating a near-term catalyst window around July 20-21 and ongoing compliance risk thereafter.
What to watch
Traders should focus on the NYSE cure test timing (monthly $1 closes and 30-trading-day average) rather than the split itself, since compliance outcomes drive the real risk premium.
Background
Cango previously received an NYSE minimum-price deficiency notice after its Class A average closing price stayed below $1 for 30 consecutive trading days.
Ticker impact
Cango set July 20 for a 10-for-1 reverse split, with post-split trading starting July 21 and NYSE compliance cure conditions still pending.
Likely short-term volatility around July 20-21 as the split executes and traders reassess compliance odds; direction depends on whether the $1 close and 30-day average requirements are met.
The article discloses the exact consolidation ratio and effective dates, plus the ongoing NYSE cure framework tied to $1 closes and a 30-trading-day average, which can drive risk repricing even without a market-cap increase.
Market effects
Limited direct sector read-across; reverse-split mechanics are company-specific, though it can affect sentiment toward micro/low-priced NYSE listings.
Primarily US-listed microcap liquidity and NYSE compliance sentiment.
Low, as the event is an NYSE listing compliance and capital-structure adjustment rather than a global macro catalyst.
Counterpoint
The reverse split does not change fundamentals or market cap, so price action may be more mechanical than predictive of long-term viability.
Key entities
- companyCango
NYSE-listed company executing a 10-for-1 reverse split to address an NYSE minimum-price deficiency.
- venue/regulatorNew York Stock Exchange (NYSE)
Exchange that issued the minimum-price deficiency notice and sets the $1 close and 30-trading-day average compliance tests.
